Previous in vivo and in vitro studies by our group showed that QC exhibited activity against BPH via the promotion of apoptosis, suppression of the EGFR/STAT3 signaling pathway and regulating the expression of sex hormones as well as their receptors (21–24). The gene discussed is STAT3; the disease is benign prostatic hyperplasia.